Your search returned 1590 results.

Results
	1081.	The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes. [electronic resource] by Benter, Ibrahim F Sarkhou, Fatima Al-Khaldi, Abeer T Chandrasekhar, Bindu Attur, Sreeja Dhaunsi, Gursev S Yousif, Mariam H M Akhtar, Saghir Producer: 20160425 In: Journal of drug targeting vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1082.	Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program. [electronic resource] by Schramm, Amelie Friedl, Thomas W P Schochter, Fabienne Scholz, Christoph de Gregorio, Nikolaus Huober, Jens Rack, Brigitte Trapp, Elisabeth Alunni-Fabbroni, Marianna Müller, Volkmar Schneeweiss, Andreas Pantel, Klaus Meier-Stiegen, Franziska Hartkopf, Andreas Taran, Florin-Andrei Wallwiener, Diethelm Janni, Wolfgang Fehm, Tanja Producer: 20160523 In: Archives of gynecology and obstetrics vol. 293 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1083.	MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells. [electronic resource] by Fisher, James Neil Terao, Mineko Fratelli, Maddalena Kurosaki, Mami Paroni, Gabriela Zanetti, Adriana Gianni, Maurizio Bolis, Marco Lupi, Monica Tsykin, Anna Goodall, Gregory J Garattini, Enrico Producer: 20160407 In: Oncotarget vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1084.	PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer. [electronic resource] by Majewski, Ian J Nuciforo, Paolo Mittempergher, Lorenza Bosma, Astrid J Eidtmann, Holger Holmes, Eileen Sotiriou, Christos Fumagalli, Debora Jimenez, Jose Aura, Claudia Prudkin, Ludmila Díaz-Delgado, Maria Carmen de la Peña, Lorena Loi, Sherene Ellis, Catherine Schultz, Nikolaus de Azambuja, Evandro Harbeck, Nadia Piccart-Gebhart, Martine Bernards, René Baselga, José Producer: 20150615 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1085.	Co-targeting estrogen receptor and HER2 pathways in breast cancer. [electronic resource] by Mehta, Arjun Tripathy, Debu Producer: 20140831 In: Breast (Edinburgh, Scotland) vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1086.	HER2 signaling regulates HER2 localization and membrane retention. [electronic resource] by Jeong, Jaekwang Kim, Wonnam Kim, Lark Kyun VanHouten, Joshua Wysolmerski, John J Producer: 20170830 In: PloS one vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1087.	Systemic therapy for HER2-positive early-stage breast cancer. [electronic resource] by Mathew, Aju Romond, Edward H Producer: 20171219 In: Current problems in cancer vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1088.	Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment. [electronic resource] by Shu, Tong Li, Yi Wu, Xiaowei Li, Bin Liu, Zhihua Producer: 20171205 In: Cancer letters vol. 411 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1089.	Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts. [electronic resource] by Huber, L C Künzler, P Boyce, S H Michel, B A Gay, R E Ink, B S Gay, S Producer: 20080304 In: Annals of the rheumatic diseases vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1090.	Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor. [electronic resource] by Witters, Lois M Witkoski, Amy Planas-Silva, Maricarmen D Berger, Mark Viallet, Jean Lipton, Allan Producer: 20070329 In: Oncology reports vol. 17 Availability: No items available. Save to lists Add to cart (remove)
	1091.	[New treatment approaches in breast cancer]. [electronic resource] by Spirig, Christian Thürlimann, Beat Huober, Jens Producer: 20080829 In: Therapeutische Umschau. Revue therapeutique vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1092.	Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib. [electronic resource] by Cathomas, R von Moos, R Producer: 20091109 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1093.	EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. [electronic resource] by Guo, Deliang Prins, Robert M Dang, Julie Kuga, Daisuke Iwanami, Akio Soto, Horacio Lin, Kelly Y Huang, Tiffany T Akhavan, David Hock, M Benjamin Zhu, Shaojun Kofman, Ava A Bensinger, Steve J Yong, William H Vinters, Harry V Horvath, Steve Watson, Andrew D Kuhn, John G Robins, H Ian Mehta, Minesh P Wen, Patrick Y DeAngelis, Lisa M Prados, Michael D Mellinghoff, Ingo K Cloughesy, Timothy F Mischel, Paul S Producer: 20100305 In: Science signaling vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1094.	[Management of metastatic HER2-positive breast cancer: present and future]. [electronic resource] by Guiu, S Coudert, B Favier, L Arnould, L Fumoleau, P Producer: 20100405 In: Bulletin du cancer vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1095.	Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib. [electronic resource] by Kaklamani, Virginia G Siziopikou, Kalliopi Scholtens, Denise Lacouture, Mario Gordon, Jennifer Uthe, Regina Meservey, Caitlin Hansen, Nora Khan, Seema A Jeruss, Jacqueline S Bethke, Kevin Cianfrocca, Mary Rosen, Steven Von Roenn, Jamie Wayne, Jeffrey Parimi, Vamsi Jovanovic, Borko Gradishar, William Producer: 20120822 In: Breast cancer research and treatment vol. 132 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1096.	[Her2 positive breast cancer: practices]. [electronic resource] by Campone, Mario Berton-Rigaud, Dominique Bourbouloux, Emmanuelle Sophie, Sadot Zanetti, Alain Frenel, Jean-Sébastien Producer: 20110525 In: Bulletin du cancer vol. 98 Availability: No items available. Save to lists Add to cart (remove)
	1097.	[HER2 ASCO guidelines. The answer to everything?]. [electronic resource] by Burandt, E Sauter, G Producer: 20110330 In: Der Pathologe vol. 31 Suppl 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1098.	Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers. [electronic resource] by Ghosh, Ritwik Narasanna, Archana Wang, Shizhen Emily Liu, Shuying Chakrabarty, Anindita Balko, Justin M González-Angulo, Ana María Mills, Gordon B Penuel, Elicia Winslow, John Sperinde, Jeff Dua, Rajiv Pidaparthi, Sailaja Mukherjee, Ali Leitzel, Kim Kostler, Wolfgang J Lipton, Allan Bates, Michael Arteaga, Carlos L Producer: 20110421 In: Cancer research vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1099.	Ras-induced resistance to lapatinib is overcome by MEK inhibition. [electronic resource] by Zoppoli, Gabriele Moran, Eva Soncini, Debora Cea, Michele Garuti, Anna Rocco, Ilaria Cirmena, Gabriella Grillo, Valentina Bagnasco, Luca Icardi, Giancarlo Ansaldi, Filippo Parodi, Silvio Patrone, Franco Ballestrero, Alberto Nencioni, Alessio Producer: 20100722 In: Current cancer drug targets vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1100.	Trastuzumab emtansine in breast cancer. [electronic resource] by Dirix, Luc Y Rutten, Annemie Huget, Philippe Dirix, Marie Producer: 20150804 In: Expert opinion on biological therapy vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1590 results.